SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009291
Filing Date
2016-11-04
Accepted
2016-11-04 09:01:10
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20160930x10q.htm 10-Q 1204847
2 EX-31.1 glyc-20160930ex311fdfe11.htm EX-31.1 18284
3 EX-31.2 glyc-20160930ex312460a7f.htm EX-31.2 17335
4 EX-32.1 glyc-20160930ex3217de671.htm EX-32.1 10326
  Complete submission text file 0001558370-16-009291.txt   4446792

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20160930.xml EX-101.INS 917955
6 EX-101.SCH glyc-20160930.xsd EX-101.SCH 27105
7 EX-101.CAL glyc-20160930_cal.xml EX-101.CAL 31291
8 EX-101.DEF glyc-20160930_def.xml EX-101.DEF 123202
9 EX-101.LAB glyc-20160930_lab.xml EX-101.LAB 270314
10 EX-101.PRE glyc-20160930_pre.xml EX-101.PRE 222483
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 161973780
SIC: 2834 Pharmaceutical Preparations